Dr Anik, the former president of pharmaceutical development services (PDS) at Patheon will lead Althea’s expansion of its product development, clinical trial and commercial manufacturing services. Magda Marquet and Francois Ferre, the company’s co-founders and former co-CEOs, will continue to serve Althea as co-chairmen of the board of directors.
Dr Anik began his career at Syntex, serving in positions of increasing responsibility leading to the position of vice president and program director. He also served as senior director of pharmaceutical development and operations for the biotechnology company Neurex, before most recently joining Patheon, where he was responsible for building and managing Patheon’s global PDS business.
Dr Marquet said: “We are delighted to welcome Dr Anik to Althea and feel that his background and expertise is a wonderful match for the company. He is a rare blend of scientist, manager and leader, and we are excited about Althea’s continued success with Shabbir at the helm.
“As we continue to grow to serve our clients, Shabbir’s experience in manufacturing, his understanding of the critical interplay of services in bringing a product to commercial success, and his ability to manage these activities across the globe will be invaluable to Althea.”